American Well Co. (NYSE:AMWL) Director Sells $17,302.82 in Stock

American Well Co. (NYSE:AMWL) Director Deborah C. Jackson sold 42,202 shares of the company’s stock in a transaction that occurred on Monday, June 24th. The shares were sold at an average price of $0.41, for a total transaction of $17,302.82. Following the completion of the sale, the director now owns 636,683 shares of the company’s stock, valued at approximately $261,040.03. The sale was disclosed in a filing with the SEC, which is accessible through this link.

American Well Stock Down 10.5 %

AMWL stock traded down $0.04 during midday trading on Wednesday, reaching $0.36. The company had a trading volume of 2,278,002 shares, compared to its average volume of 1,949,729. The company has a 50 day moving average of $0.47 and a two-hundred day moving average of $0.86. American Well Co. has a 1 year low of $0.35 and a 1 year high of $2.47.

American Well (NYSE:AMWL) last posted its quarterly earnings results on Wednesday, May 1st. The company reported ($0.25) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.18) by ($0.07). The company had revenue of $59.52 million during the quarter, compared to analyst estimates of $61.10 million. American Well had a negative return on equity of 46.76% and a negative net margin of 137.32%. During the same period last year, the company posted ($0.24) earnings per share. On average, equities analysts anticipate that American Well Co. will post -0.75 earnings per share for the current fiscal year.

Institutional Investors Weigh In On American Well

Hedge funds and other institutional investors have recently made changes to their positions in the company. Healthcare of Ontario Pension Plan Trust Fund acquired a new position in American Well during the first quarter worth $1,284,000. Acadian Asset Management LLC increased its holdings in shares of American Well by 193.0% during the 1st quarter. Acadian Asset Management LLC now owns 2,083,805 shares of the company’s stock valued at $1,687,000 after acquiring an additional 1,372,582 shares during the last quarter. Senvest Management LLC raised its stake in shares of American Well by 2.2% in the 4th quarter. Senvest Management LLC now owns 23,529,964 shares of the company’s stock valued at $35,060,000 after acquiring an additional 507,340 shares in the last quarter. GSA Capital Partners LLP lifted its holdings in American Well by 75.5% in the 3rd quarter. GSA Capital Partners LLP now owns 716,830 shares of the company’s stock worth $839,000 after purchasing an additional 308,418 shares during the last quarter. Finally, Vanguard Group Inc. boosted its position in American Well by 1.4% during the first quarter. Vanguard Group Inc. now owns 13,398,096 shares of the company’s stock worth $10,862,000 after purchasing an additional 190,922 shares during the period. 56.05% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on AMWL. Morgan Stanley reduced their target price on American Well from $1.75 to $1.00 and set an “equal weight” rating for the company in a report on Monday, April 15th. UBS Group reduced their price objective on American Well from $1.50 to $0.60 and set a “neutral” rating for the company in a research note on Thursday, May 23rd. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of American Well in a research note on Thursday, May 2nd.

American Well Company Profile

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.